Literature DB >> 11665497

Factors determining outcome in elderly patients with severe COPD on long-term domiciliary oxygen therapy.

H Katsura1, M Ogata, K Kida.   

Abstract

The objective of the present study was to identify factors that determine outcome in elderly patients receiving long term domiciliary oxygen therapy (LTOT) for chronic obstructive pulmonary disease (COPD). One hundred fifty-seven COPD patients (121 male, 36 female) receiving LTOT were followed-up from 1983 to 1994. Univariate and multivariate analysis by Cox's proportional hazards ratio model and Kaplan-Meier survival estimates were used to quantify the relationship among a total of 34 baseline variables and overall mortality. By December 31, 1995, 96 patients (61.2%) had died and 13 (8.3%) were unavailable for follow up. Mean age of the patients was 79.2 yrs and mean duration of LTOT was 2.81 yrs. The mean FEV1 was 0.80 L and mean FEV1/FVC was 48%. The overall survival was poor and 5-yr survival was 21.6% (median survival: 3.01 yrs). Among the variables tested by univariate analysis, factors associated with poor outcome were as follows: %IBW < or = 85 (HR = 2.15, p < 0.001), serum albumin (g/dl) < or = 3.5 (1.81, p < 0.01), hemoglobin (g/dl) < or = 11.0 (1.86, p < 0.01), FEV1/FVC > 50% (0.63, p < 0.05), and high dyspnea ranking (grade 4 or 5) (1.74, p < 0.05). The coexistence of bronchiectasis (3.96, p < 0.01) and malignancy (1.85, p < 0.01) also contributed to poor outcome. Multivariate analysis showed that independent prognostic factors influencing outcome included: nutritional status (%IBW) (HR = 2.08, p < 0.01), dyspnea ranking (2.04, p < 0.01), coexistence of malignancy (2.02, p < 0.01), and FEV1/FVC (0.52, p < 0.01). We conclude that the outcome in elderly COPD patients receiving LTOT is poor, and that outcome is independently influenced by four major factors: malnutrition, severity of dyspnea, coexistence of malignancy, and airflow obstruction.

Entities:  

Mesh:

Year:  2001        PMID: 11665497

Source DB:  PubMed          Journal:  Monaldi Arch Chest Dis        ISSN: 1122-0643


  6 in total

Review 1.  The pharmacological approach to the elderly COPD patient.

Authors:  Timothy E Albertson; Michael Schivo; Amir A Zeki; Samuel Louie; Mark E Sutter; Mark Avdalovic; Andrew L Chan
Journal:  Drugs Aging       Date:  2013-07       Impact factor: 3.923

Review 2.  Severe chronic obstructive pulmonary disease.

Authors:  Ken Y Yoneda; Richart W Harper; Samuel Louie
Journal:  Clin Rev Allergy Immunol       Date:  2003-10       Impact factor: 8.667

3.  Stereotactic body radiotherapy for chronic obstructive pulmonary disease patients undergoing or eligible for long-term domiciliary oxygen therapy.

Authors:  Yu Hara; Atsuya Takeda; Takahisa Eriguchi; Naoko Sanuki; Yousuke Aoki; Shuichi Nishimura; Tatsuji Enomoto; Masaharu Shinkai; Akihiko Kawana; Takeshi Kaneko
Journal:  J Radiat Res       Date:  2015-10-20       Impact factor: 2.724

4.  Impact of bronchiectasis on outcomes of hospitalized patients with acute exacerbation of chronic obstructive pulmonary disease: A propensity matched analysis.

Authors:  Ernesto Crisafulli; Mónica Guerrero; Antonella Ielpo; Adrian Ceccato; Arturo Huerta; Albert Gabarrús; Néstor Soler; Alfredo Chetta; Antoni Torres
Journal:  Sci Rep       Date:  2018-06-18       Impact factor: 4.379

5.  A Retrospective Analysis of Nutritional Parameters in Chronic Obstructive Pulmonary Disease between Sexes.

Authors:  Ugur Gonlugur; Tanseli E Gonlugur
Journal:  J Clin Biochem Nutr       Date:  2007-11       Impact factor: 3.114

Review 6.  Bronchiectasis as a Comorbidity of Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-Analysis.

Authors:  Qingxia Du; Jianmin Jin; Xiaofang Liu; Yongchang Sun
Journal:  PLoS One       Date:  2016-03-15       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.